| regulation of cytokine production | GO:0001817 | 266 | 0.609 | |
| cytokine production | GO:0001816 | 319 | 0.562 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.447 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.431 | |
| urogenital system development | GO:0001655 | 261 | 0.387 | |
| amine metabolic process | GO:0009308 | 45 | 0.385 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.355 | |
| t cell activation | GO:0042110 | 289 | 0.353 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.343 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.341 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.337 | |
| spermatogenesis | GO:0007283 | 284 | 0.296 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.281 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.272 | |
| regulation of secretion | GO:0051046 | 274 | 0.269 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.267 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.264 | |
| nephron development | GO:0072006 | 109 | 0.262 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.255 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.247 | |
| embryonic placenta development | GO:0001892 | 98 | 0.232 | |
| placenta development | GO:0001890 | 140 | 0.214 | |
| immune effector process | GO:0002252 | 321 | 0.206 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.206 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.204 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.204 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.201 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.199 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.197 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.193 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.192 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.191 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.188 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.186 | |
| ossification | GO:0001503 | 216 | 0.185 | |
| skeletal system development | GO:0001501 | 356 | 0.181 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.173 | |
| gland development | GO:0048732 | 330 | 0.172 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.171 | |
| cartilage development | GO:0051216 | 140 | 0.171 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.168 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.161 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.157 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.157 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.156 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.154 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.152 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.151 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.151 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.150 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.149 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.149 | |
| skin development | GO:0043588 | 220 | 0.147 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.146 | |
| nephron epithelium development | GO:0072009 | 92 | 0.145 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.142 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.142 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.141 | |
| sensory system development | GO:0048880 | 3 | 0.140 | |
| b cell activation | GO:0042113 | 161 | 0.139 | |
| polarity specification of proximal distal axis | GO:0010085 | 2 | 0.139 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.136 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.134 | |
| kidney epithelium development | GO:0072073 | 121 | 0.134 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.134 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.134 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.131 | |
| t cell differentiation | GO:0030217 | 174 | 0.131 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.131 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.130 | |
| extracellular structure organization | GO:0043062 | 148 | 0.129 | |
| protein catabolic process | GO:0030163 | 221 | 0.128 | |
| endocrine system development | GO:0035270 | 98 | 0.128 | |
| bone development | GO:0060348 | 120 | 0.127 | |
| connective tissue development | GO:0061448 | 179 | 0.126 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.125 | |
| gtp metabolic process | GO:0046039 | 144 | 0.125 | |
| cellular homeostasis | GO:0019725 | 240 | 0.124 | |
| stem cell differentiation | GO:0048863 | 268 | 0.124 | |
| mesonephros development | GO:0001823 | 97 | 0.124 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.123 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.122 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.122 | |
| regulation of protein localization | GO:0032880 | 231 | 0.121 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.121 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.119 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.117 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.117 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.115 | |
| nephron tubule development | GO:0072080 | 84 | 0.114 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.114 | |
| hindbrain formation | GO:0021576 | 1 | 0.114 | |
| regulation of cell migration | GO:0030334 | 219 | 0.113 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.113 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.113 | |
| digestive system development | GO:0055123 | 200 | 0.112 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.111 | |
| stem cell proliferation | GO:0072089 | 117 | 0.109 | |
| cell fate determination | GO:0001709 | 32 | 0.109 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.108 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.108 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.108 | |
| prostate gland development | GO:0030850 | 48 | 0.108 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.107 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.107 | |
| protein ubiquitination | GO:0016567 | 171 | 0.107 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.104 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.103 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.103 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.103 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.102 | |
| mesenchyme morphogenesis | GO:0072132 | 32 | 0.102 | |
| mesenchyme development | GO:0060485 | 152 | 0.101 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.100 | |
| metencephalon development | GO:0022037 | 89 | 0.099 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.099 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.099 | |
| renal vesicle induction | GO:0072034 | 3 | 0.099 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.098 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.098 | |
| renal tubule development | GO:0061326 | 87 | 0.097 | |
| multicellular organism growth | GO:0035264 | 161 | 0.097 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.097 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.097 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.095 | |
| ovulation cycle | GO:0042698 | 59 | 0.095 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.095 | |
| regionalization | GO:0003002 | 337 | 0.095 | |
| telencephalon development | GO:0021537 | 186 | 0.094 | |
| regulation of cell motility | GO:2000145 | 236 | 0.094 | |
| hormone metabolic process | GO:0042445 | 86 | 0.093 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.093 | |
| regulation of cell activation | GO:0050865 | 289 | 0.092 | |
| ureteric bud development | GO:0001657 | 94 | 0.092 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.091 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.091 | |
| positive regulation of plasminogen activation | GO:0010756 | 2 | 0.091 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.090 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.090 | |
| female sex differentiation | GO:0046660 | 84 | 0.090 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.090 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.090 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.090 | |
| nephric duct formation | GO:0072179 | 4 | 0.089 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.089 | |
| skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | GO:0014834 | 3 | 0.089 | |
| lung development | GO:0030324 | 164 | 0.089 | |
| neuron migration | GO:0001764 | 122 | 0.088 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.088 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.087 | |
| male gamete generation | GO:0048232 | 285 | 0.087 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.086 | |
| epithelial mesenchymal signaling involved in prostate gland development | GO:0060738 | 2 | 0.085 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.085 | |
| protein maturation | GO:0051604 | 176 | 0.084 | |
| ear morphogenesis | GO:0042471 | 118 | 0.084 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.084 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.084 | |
| pallium development | GO:0021543 | 120 | 0.083 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.083 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.083 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.081 | |
| lung induction | GO:0060492 | 3 | 0.080 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.080 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.080 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.080 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.079 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.079 | |
| non canonical wnt signaling pathway via mapk cascade | GO:0038030 | 3 | 0.079 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.079 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.078 | |
| renal inner medulla development | GO:0072053 | 3 | 0.078 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.078 | |
| gastrulation | GO:0007369 | 116 | 0.078 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.077 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.077 | |
| peptide transport | GO:0015833 | 133 | 0.077 | |
| trachea cartilage morphogenesis | GO:0060535 | 4 | 0.077 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.077 | |
| positive regulation of b cell activation | GO:0050871 | 49 | 0.077 | |
| cation homeostasis | GO:0055080 | 212 | 0.076 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.076 | |
| kidney development | GO:0001822 | 213 | 0.076 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.075 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.075 | |
| camera type eye development | GO:0043010 | 266 | 0.074 | |
| female gonad development | GO:0008585 | 71 | 0.074 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.074 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.074 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.073 | |
| germ cell development | GO:0007281 | 185 | 0.073 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.073 | |
| cation transport | GO:0006812 | 399 | 0.073 | |
| cytokine secretion | GO:0050663 | 72 | 0.073 | |
| oviduct development | GO:0060066 | 3 | 0.073 | |
| renal outer medulla development | GO:0072054 | 2 | 0.073 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.073 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.072 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.071 | |
| gonad development | GO:0008406 | 141 | 0.071 | |
| gtp catabolic process | GO:0006184 | 143 | 0.071 | |
| mesoderm development | GO:0007498 | 100 | 0.071 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.071 | |
| neuron projection guidance | GO:0097485 | 141 | 0.071 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.070 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.070 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.070 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.070 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.070 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.070 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.069 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.069 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.069 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.069 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.069 | |
| regulation of renal sodium excretion | GO:0035813 | 3 | 0.069 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.069 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.069 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.069 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.068 | |
| mapk cascade | GO:0000165 | 281 | 0.068 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.068 | |
| regulation of anagen | GO:0051884 | 1 | 0.067 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.067 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.067 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.067 | |
| metanephric nephron development | GO:0072210 | 34 | 0.067 | |
| inner medullary collecting duct development | GO:0072061 | 2 | 0.067 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.067 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.067 | |
| endocytosis | GO:0006897 | 168 | 0.067 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.067 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.067 | |
| forebrain development | GO:0030900 | 302 | 0.067 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.067 | |
| palate development | GO:0060021 | 76 | 0.067 | |
| stem cell development | GO:0048864 | 219 | 0.067 | |
| axonogenesis | GO:0007409 | 274 | 0.066 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.066 | |
| learning or memory | GO:0007611 | 148 | 0.066 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.066 | |
| neural tube development | GO:0021915 | 160 | 0.066 | |
| transmembrane transport | GO:0055085 | 412 | 0.066 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.066 | |
| cerebral cortex development | GO:0021987 | 86 | 0.066 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.066 | |
| ovarian follicle development | GO:0001541 | 40 | 0.065 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.065 | |
| female somatic sex determination | GO:0019101 | 1 | 0.065 | |
| peptide secretion | GO:0002790 | 114 | 0.065 | |
| respiratory system development | GO:0060541 | 190 | 0.065 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.065 | |
| cardiac chamber development | GO:0003205 | 108 | 0.064 | |
| neural tube closure | GO:0001843 | 90 | 0.064 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.064 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.064 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.064 | |
| epidermis development | GO:0008544 | 187 | 0.064 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.064 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.064 | |
| cell fate commitment | GO:0045165 | 210 | 0.064 | |
| respiratory tube development | GO:0030323 | 167 | 0.064 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.064 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.063 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.063 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.063 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.063 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.063 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.063 | |
| cerebellum formation | GO:0021588 | 1 | 0.062 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.062 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.062 | |
| regulation of peptide hormone secretion | GO:0090276 | 75 | 0.062 | |
| developmental maturation | GO:0021700 | 193 | 0.062 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.061 | |
| neural tube formation | GO:0001841 | 108 | 0.061 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.061 | |
| protein processing | GO:0016485 | 163 | 0.060 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.060 | |
| male sex differentiation | GO:0046661 | 109 | 0.060 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.060 | |
| amide transport | GO:0042886 | 138 | 0.060 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.060 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.060 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.059 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.059 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.059 | |
| ubiquitin dependent smad protein catabolic process | GO:0030579 | 2 | 0.059 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.059 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.059 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.059 | |
| t cell proliferation | GO:0042098 | 120 | 0.058 | |
| mesoderm formation | GO:0001707 | 62 | 0.058 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.058 | |
| hindbrain development | GO:0030902 | 128 | 0.058 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.058 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.058 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.058 | |
| lateral line system development | GO:0048925 | 1 | 0.058 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.058 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.057 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.057 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.057 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.057 | |
| renal system development | GO:0072001 | 225 | 0.057 | |
| artery development | GO:0060840 | 53 | 0.057 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.057 | |
| collagen fibril organization | GO:0030199 | 32 | 0.056 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.056 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.056 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.056 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.056 | |
| adaptive immune response | GO:0002250 | 155 | 0.056 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.056 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.056 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.055 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.055 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.055 | |
| protein secretion | GO:0009306 | 111 | 0.055 | |
| somite development | GO:0061053 | 81 | 0.055 | |
| cerebellum development | GO:0021549 | 77 | 0.054 | |
| regulation of protein tyrosine kinase activity | GO:0061097 | 17 | 0.054 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.054 | |
| planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:0061350 | 2 | 0.054 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.053 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.053 | |
| actin filament organization | GO:0007015 | 113 | 0.053 | |
| epithelial cell development | GO:0002064 | 159 | 0.053 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.053 | |
| heart growth | GO:0060419 | 45 | 0.053 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.053 | |
| stem cell maintenance | GO:0019827 | 130 | 0.053 | |
| branching involved in mammary gland duct morphogenesis | GO:0060444 | 27 | 0.053 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.053 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.052 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.052 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.052 | |
| regulation of protein transport | GO:0051223 | 163 | 0.052 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.052 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.052 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.052 | |
| cell maturation | GO:0048469 | 127 | 0.051 | |
| cell differentiation involved in embryonic placenta development | GO:0060706 | 26 | 0.051 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.051 | |
| ear development | GO:0043583 | 200 | 0.051 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.051 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.051 | |
| limbic system development | GO:0021761 | 72 | 0.050 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.050 | |
| renal capsule morphogenesis | GO:0072128 | 1 | 0.050 | |
| hair cycle | GO:0042633 | 90 | 0.050 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.050 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.050 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.050 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.050 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.050 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.050 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.049 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.049 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.049 | |
| heart morphogenesis | GO:0003007 | 178 | 0.049 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.049 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.049 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.049 | |
| regulation of alpha beta t cell differentiation | GO:0046637 | 35 | 0.049 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.048 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.048 | |
| cognition | GO:0050890 | 149 | 0.048 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.048 | |
| cerebellar cortex development | GO:0021695 | 48 | 0.048 | |
| ventricular cardiac muscle cell action potential | GO:0086005 | 4 | 0.048 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.048 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.048 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.047 | |
| regulation of smoothened signaling pathway | GO:0008589 | 58 | 0.047 | |
| male gonad development | GO:0008584 | 88 | 0.047 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.047 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.047 | |
| digestive tract development | GO:0048565 | 190 | 0.047 | |
| blastocyst development | GO:0001824 | 80 | 0.047 | |
| renal capsule specification | GO:0072130 | 1 | 0.047 | |
| interleukin 8 production | GO:0032637 | 4 | 0.046 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.046 | |
| dna templated transcriptional preinitiation complex assembly | GO:0070897 | 4 | 0.046 | |
| tube closure | GO:0060606 | 91 | 0.046 | |
| non canonical wnt signaling pathway involved in heart development | GO:0061341 | 3 | 0.046 | |
| cell division | GO:0051301 | 120 | 0.046 | |
| intracellular protein transport | GO:0006886 | 204 | 0.046 | |
| water homeostasis | GO:0030104 | 27 | 0.046 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.046 | |
| regulation of interleukin 8 secretion | GO:2000482 | 2 | 0.046 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.045 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.045 | |
| regulation of cell cell adhesion mediated by cadherin | GO:2000047 | 2 | 0.045 | |
| hexose metabolic process | GO:0019318 | 98 | 0.045 | |
| response to nutrient levels | GO:0031667 | 109 | 0.045 | |
| tissue homeostasis | GO:0001894 | 115 | 0.045 | |
| maintenance of cell number | GO:0098727 | 3 | 0.045 | |
| axon guidance | GO:0007411 | 141 | 0.045 | |
| prostate gland stromal morphogenesis | GO:0060741 | 2 | 0.045 | |
| muscle system process | GO:0003012 | 141 | 0.045 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.045 | |
| hair follicle development | GO:0001942 | 85 | 0.044 | |
| biomineral tissue development | GO:0031214 | 64 | 0.044 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.044 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.044 | |
| renal sodium excretion | GO:0035812 | 3 | 0.044 | |
| insulin secretion | GO:0030073 | 89 | 0.044 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.044 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.044 | |
| tissue migration | GO:0090130 | 68 | 0.044 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.044 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.044 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.043 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.043 | |
| regulation of defense response | GO:0031347 | 233 | 0.043 | |
| paraxial mesoderm development | GO:0048339 | 18 | 0.043 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.043 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.043 | |
| positive regulation of growth | GO:0045927 | 104 | 0.043 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.042 | |
| protein localization to organelle | GO:0033365 | 185 | 0.042 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.042 | |
| establishment or maintenance of polarity of embryonic epithelium | GO:0016332 | 1 | 0.042 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.042 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.041 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.041 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.041 | |
| inflammatory response | GO:0006954 | 244 | 0.041 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.041 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.041 | |
| neuron death | GO:0070997 | 154 | 0.041 | |
| regulation of plasminogen activation | GO:0010755 | 4 | 0.041 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.040 | |
| alpha beta t cell differentiation involved in immune response | GO:0002293 | 30 | 0.040 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.040 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.040 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.040 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.040 | |
| dna recombination | GO:0006310 | 92 | 0.040 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.040 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.040 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.040 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.040 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.040 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.040 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.040 | |
| synapse organization | GO:0050808 | 125 | 0.040 | |
| cervix development | GO:0060067 | 2 | 0.039 | |
| lung field specification | GO:0060424 | 3 | 0.039 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.039 | |
| b cell differentiation | GO:0030183 | 78 | 0.039 | |
| body morphogenesis | GO:0010171 | 45 | 0.039 | |
| endothelium development | GO:0003158 | 45 | 0.039 | |
| neuroepithelial cell differentiation | GO:0060563 | 37 | 0.039 | |
| regulation of protein processing | GO:0070613 | 96 | 0.039 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.039 | |
| negative regulation of mesenchymal cell proliferation | GO:0072201 | 3 | 0.039 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.039 | |
| glucose homeostasis | GO:0042593 | 128 | 0.039 | |
| bone mineralization | GO:0030282 | 54 | 0.039 | |
| odontogenesis | GO:0042476 | 78 | 0.039 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.039 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.038 | |
| interleukin 8 secretion | GO:0072606 | 3 | 0.038 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.038 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.038 | |
| bone morphogenesis | GO:0060349 | 78 | 0.038 | |
| glandular epithelial cell differentiation | GO:0002067 | 38 | 0.038 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.038 | |
| tongue development | GO:0043586 | 18 | 0.038 | |
| prostate gland epithelium morphogenesis | GO:0060740 | 31 | 0.038 | |
| positive regulation of transcription from rna polymerase ii promoter by glucose | GO:0000432 | 3 | 0.038 | |
| limb development | GO:0060173 | 166 | 0.038 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.038 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.038 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.038 | |
| organ growth | GO:0035265 | 117 | 0.038 | |
| positive regulation of organ growth | GO:0046622 | 29 | 0.038 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.038 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.038 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.037 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.037 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.037 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.037 | |
| type b pancreatic cell proliferation | GO:0044342 | 10 | 0.037 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.037 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.037 | |
| bone remodeling | GO:0046849 | 53 | 0.037 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.037 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.037 | |
| wnt signaling pathway calcium modulating pathway | GO:0007223 | 2 | 0.037 | |
| neurotransmitter transport | GO:0006836 | 76 | 0.037 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.036 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.036 | |
